{
    "2020-11-19": [
        [
            {
                "time": "2020-11-19",
                "original_text": "人 民 金 融 · 创 新 药 指 数 涨 1 . 4 % | 贝 达 药 业 重 磅 新 药 获 批 上 市 ， 多 家 公 司 布 局 肥 胖 症 药 物",
                "features": {
                    "keywords": [
                        "创新药指数",
                        "贝达药业",
                        "重磅新药",
                        "获批上市",
                        "肥胖症药物"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-19",
                "original_text": "贝 达 药 业 盐 酸 恩 沙 替 尼 药 品 注 册 审 批 完 毕 等 待 制 证",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "盐酸恩沙替尼",
                        "药品注册",
                        "审批完毕",
                        "等待制证"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-19",
                "original_text": "午 间 公 告 2 0 2 0 年 1 1 月 1 9 日 星 期 四",
                "features": {
                    "keywords": [
                        "午间公告",
                        "2020年11月19日"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-19",
                "original_text": "贝 达 药 业 ( 3 0 0 5 5 8 . S Z ) ： 盐 酸 恩 沙 替 尼 胶 囊 注 册 申 请 处 待 制 证 阶 段",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "盐酸恩沙替尼胶囊",
                        "注册申请",
                        "待制证阶段"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-11-19",
                "original_text": "贝 达 药 业 盐 酸 恩 莎 替 尼 获 批 上 市",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "盐酸恩莎替尼",
                        "获批上市"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}